Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly
Authors
Keywords
Acromegaly, AcroQoL, Patient-reported outcomes, ACRODAT
Journal
Pituitary
Volume 20, Issue 6, Pages 692-701
Publisher
Springer Nature
Online
2017-09-12
DOI
10.1007/s11102-017-0835-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
- (2016) Jakob Dal et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey
- (2015) C. Schofl et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study
- (2015) Andrea Giustina et al. Pituitary
- Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations
- (2014) Martin Bidlingmaier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
- (2013) Laurence Katznelson et al. Endocrine Practice
- Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission
- (2013) Robert M. Starke et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY
- (2012) A. J. van der Lely et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery
- (2010) Kristine Z Rubeck et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly
- (2009) C Berg et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension
- (2009) Shlomo Melmed et al. Pituitary
- A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
- (2008) I M Holdaway et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance
- (2008) Maria P Matta et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant
- (2008) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Wide variation in surgical outcomes for acromegaly in the UK
- (2007) P. R. Bates et al. CLINICAL ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search